Pasithea Therapeutics (KTTA) Accumulated Depreciation & Amortization (2022 - 2025)
Pasithea Therapeutics recorded quarterly Accumulated Depreciation & Amortization of $49000.0 in Q4 2025, up 53.12% quarter-over-quarter from $32000.0 in Q3 2025, and up 15.69% year-over-year from $42353.0 in Q4 2024.
Pasithea Therapeutics' Accumulated Depreciation & Amortization history runs 4 years deep, the most recent figure standing at $49000.0 for Q4 2025.
- In Q4 2025, Accumulated Depreciation & Amortization rose 15.69% year-over-year to $49000.0; the TTM figure through Dec 2025 stood at $49000.0 (up 15.69% YoY), while the FY2025 annual figure was $49000.0, up 15.69% from the prior year.
- Accumulated Depreciation & Amortization came in at $49000.0 for Q4 2025 at Pasithea Therapeutics, up from $32000.0 in the prior quarter.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of $49000.0 in Q4 2025 to a low of $3559.0 in Q4 2022.
- A 4-year average of $30565.2 and a median of $32000.0 in 2025 frame the typical range for Accumulated Depreciation & Amortization.
- Across the five-year window, Accumulated Depreciation & Amortization jumped 559.96% in 2023 and retreated 25.42% in 2024, its largest moves.
- Pasithea Therapeutics' Accumulated Depreciation & Amortization stood at $3559.0 in 2022, then surged by 559.96% to $23488.0 in 2023, then soared by 80.32% to $42353.0 in 2024, then increased by 15.69% to $49000.0 in 2025.
- According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods registered $49000.0, $32000.0, and $47939.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Pasithea Therapeutics | 17.41 Mn | 17.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 49,000.00 |
| Dec 31, 2025 | 49,000.00 |
| Sep 30, 2025 | 49,000.00 |
| Sep 30, 2025 | 49,000.00 |
| Jun 30, 2025 | 47,939.00 |
| Jun 30, 2025 | 47,939.00 |
| Mar 31, 2025 | 43,981.00 |
| Mar 31, 2025 | 43,981.00 |
| Dec 31, 2024 | 42,353.00 |
| Dec 31, 2024 | 42,353.00 |
| Sep 30, 2024 | 5,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Jun 30, 2024 | 32,920.00 |
| Jun 30, 2024 | 32,920.00 |
| Mar 31, 2024 | 28,205.00 |
| Mar 31, 2024 | 28,205.00 |
| Dec 31, 2023 | 23,488.00 |
| Dec 31, 2023 | 23,488.00 |
| Sep 30, 2023 | 18,772.00 |
| Sep 30, 2023 | 18,772.00 |
| Dec 31, 2022 | 3,559.00 |
| Dec 31, 2022 | 3,559.00 |